These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11413997)

  • 1. [Are transdermic estrogens cardioprotective?].
    Blümel JE; Campodónico I
    Rev Med Chil; 2001 Apr; 129(4):433-40. PubMed ID: 11413997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review.
    L'hermite M; Simoncini T; Fuller S; Genazzani AR
    Maturitas; 2008; 60(3-4):185-201. PubMed ID: 18775609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmenopausal hormone therapy: new questions and the case for new clinical trials.
    Manson JE; Bassuk SS; Harman SM; Brinton EA; Cedars MI; Lobo R; Merriam GR; Miller VM; Naftolin F; Santoro N
    Menopause; 2006; 13(1):139-47. PubMed ID: 16607110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Estrogen and cardiovascular diseases].
    Mikkola T; Tikkanen MJ
    Duodecim; 2003; 119(22):2191-7. PubMed ID: 14702808
    [No Abstract]   [Full Text] [Related]  

  • 6. [The role of estradiol metabolites in prevention of cardiovascular diseases by hormone substitution in postmenopause].
    Lippert TH; Seeger H; Mueck AO
    Zentralbl Gynakol; 1999; 121(10):467-72. PubMed ID: 10573819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy and cardiovascular disease.
    McPherson R; Tardif JC; Jolly E
    Can J Cardiol; 2001 Nov; 17 Suppl D():32D-37D. PubMed ID: 11726994
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of oral and transdermal hormone replacement therapy on internal carotid artery pulsatility indices in postmenopausal women. A prospective, randomized, comparative study.
    Sendağ F; Terek MC; Karadadaş N; Bilgin O
    J Reprod Med; 2001 Nov; 46(11):962-8. PubMed ID: 11762152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
    Rosano GM; Vitale C; Fini M
    Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy?
    Shulman LP
    J Fam Pract; 2004 Jul; Suppl():S13-7. PubMed ID: 15251108
    [No Abstract]   [Full Text] [Related]  

  • 11. Estrogen, inflammation and cardiovascular risk in women: a critical appraisal.
    Störk S; van der Schouw YT; Grobbee DE; Bots ML
    Trends Endocrinol Metab; 2004 Mar; 15(2):66-72. PubMed ID: 15036252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hormonal replacement therapy and selective estrogen receptor modulators in prevention of cardiovascular disease].
    Kozakiewicz K; Wycisk A
    Wiad Lek; 2006; 59(5-6):377-82. PubMed ID: 17017486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Historical perspective of hormone replacement therapy].
    Chanson P
    Rev Prat; 2005 Feb; 55(4):369-75. PubMed ID: 15828614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do the cardiovascular disease risks and benefits of oral versus transdermal estrogen therapy differ between perimenopausal and postmenopausal women?
    Clarkson TB; Karas RH
    Menopause; 2007; 14(6):963-7. PubMed ID: 17909452
    [No Abstract]   [Full Text] [Related]  

  • 15. Transdermal estrogen replacement therapy. An overview of today's issues.
    Alexander IM
    Adv Nurse Pract; 2000 Aug; 8(8):60-3. PubMed ID: 11761525
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect on cartilage of different forms of application of postmenopausal estrogen therapy: comparison of oral and transdermal therapy.
    Ravn P; Warming L; Christgau S; Christiansen C
    Bone; 2004 Nov; 35(5):1216-21. PubMed ID: 15542048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KEEPS: The Kronos Early Estrogen Prevention Study.
    Harman SM; Brinton EA; Cedars M; Lobo R; Manson JE; Merriam GR; Miller VM; Naftolin F; Santoro N
    Climacteric; 2005 Mar; 8(1):3-12. PubMed ID: 15804727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of transdermal estrogens on endothelial function in postmenopausal women with coronary disease.
    Blümel JE; Castelo-Branco C; Leal T; Gallardo L; Saini J; Ferron S; Haya J
    Climacteric; 2003 Mar; 6(1):38-44. PubMed ID: 12725663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen effects on neuroendocrine function: the new challenge of pulsed therapy.
    Genazzani AR; Bernardi F
    Climacteric; 2002 Jun; 5 Suppl 2():50-6. PubMed ID: 12482112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The new conundrum: do estrogens have any cardiovascular benefits?
    Clarkson TB
    Int J Fertil Womens Med; 2002; 47(2):61-8. PubMed ID: 11991432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.